(Q34984192)

5 August 2017

1 reference

title

Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). (English)

1 reference

5 August 2017

1 reference

1 reference

2

Scott A Halperin

1 reference

5 August 2017

Alexander Doroshenko

1

1 reference

5 August 2017

publication date

1 June 2009

1 reference

Expert Review of Vaccines

5 August 2017

published in

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

679-688

1 reference

Influenza vaccines: recent advances in production technologies

5 August 2017

cites work

1 reference

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

21 January 2018

1 reference

Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.

21 January 2018

1 reference

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture

21 January 2018

1 reference

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

21 January 2018

1 reference

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

21 January 2018

1 reference

Vaccine preparedness--are we ready for the next influenza pandemic?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.31

1 reference

5 August 2017

1 reference